[StemCyte-KY] Announcement of Director Change at Important Subsidiary StemCyte, Inc.

Key facts

  • [StemCyte-KY] Announcement of Director Change at Important Subsidiary StemCyte, Inc.
  • StemCyte-KY announced a change in the board of its important subsidiary, StemCyte, Inc. Director Huang Yen-Chen has stepped down, and Lu Kung-Ming, Vice Chairman of StemCyte Biotech, has been appointed as a new director, effective May 29, 115.
  • Source: PR Times
  • Date: May 29, 2026

Direct answer

StemCyte-KY announced a change in the board of its important subsidiary, StemCyte, Inc. Director Huang Yen-Chen has stepped down, and Lu Kung-Ming, Vice Chairman of StemCyte Biotech, has been appointed as a new director, effective May 29, 115.

Citation
[StemCyte-KY] Announcement of Director Change at Important Subsidiary StemCyte, Inc. (May 29, 2026), PR Times
Source
PR Times
Date
May 29, 2026
StemCyte-KY announced a change in the board of its important subsidiary, StemCyte, Inc. Director Huang Yen-Chen has stepped down, and Lu Kung-Ming, Vice Chairman of StemCyte Biotech, has been appointed as a new director, effective May 29, 115.
businessNQ 43/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: May 29, 2026 at 09:00
  • 🔍 Collected: May 30, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 31, 2026 at 17:35 (33h 35m after Collected)
1. Date of change: 115/05/29. 2. Category: Natural person director. 3. Former: Huang Yen-Chen. 4. Former background: Director of StemCyte, Inc. 5. New: Lu Kung-Ming. 6. New background: Vice Chairman of StemCyte Biotech. 7. Nature: New appointment. 8. Reason: New appointment. 9. Shares held: None. 10. Previous term: 114/03/29~115/05/28. 11. Effective date: 115/05/29. 12. Change ratio: N/A. 13. Independent director change ratio: N/A. 14. Supervisor change ratio: N/A. 15. More than 1/3 board change: Yes. 16. Other notes: None.

FAQ

What is a KY stock in Taiwan?

Companies incorporated in tax havens like Cayman Islands listed on the TWSE.

What are the key facts in this article?

StemCyte-KY announced a change in the board of its important subsidiary, StemCyte, Inc. Director Huang Yen-Chen has stepped down, and Lu Kung-Ming, Vice Chairman of StemCyte Biotech, has been appointed as a new director, effective May 29, 115.

What is the direct answer?

StemCyte-KY announced a change in the board of its important subsidiary, StemCyte, Inc. Director Huang Yen-Chen has stepped down, and Lu Kung-Ming, Vice Chairman of StemCyte Biotech, has been appointed as a new director, effective May 29, 115.

Back to Newsroom (91)